Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia A or B With Inhibitors”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Large-scale testing (Phase 3)Study completedNCT01757405
What this trial is testing

Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen

Who this might be right for
Hemophilia AHemophilia B
Baxalta now part of Shire 40
Large-scale testing (Phase 3)Study completedNCT00851721
What this trial is testing

Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor

Who this might be right for
Hemophilia A or B With InhibitorsHemophilia AHemophilia B
Baxalta now part of Shire 52
Large-scale testing (Phase 3)Ended earlyNCT02895945
What this trial is testing

BAX 802 in CHA With Inhibitors

Who this might be right for
Hemophilia A
Baxalta now part of Shire 8
Early research (Phase 1)Study completedNCT01949792
What this trial is testing

A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia A With Inhibitors+2 more
Novo Nordisk A/S 6
Post-approval studies (Phase 4)Study completedNCT00002386
What this trial is testing

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

Who this might be right for
HIV InfectionsHemophilia A
Merck Sharp & Dohme LLC 55
Testing effectiveness (Phase 2)Study completedNCT04073498
What this trial is testing

The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)

Who this might be right for
Hemophilia aHemophilia B
ApcinteX Ltd 39
Large-scale testing (Phase 3)Study completedNCT02448680
What this trial is testing

A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa

Who this might be right for
Hemophilia A With InhibitorsHemophilia B With Inhibitors
Laboratoire français de Fractionnement et de Biotechnologies 25
Large-scale testing (Phase 3)Study completedNCT03417245
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 120
Testing effectiveness (Phase 2)Study completedNCT06010953
What this trial is testing

SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment

Who this might be right for
MaleHemophilia A With InhibitorHemophilia B With Inhibitor+1 more
Hangzhou Gensciences Biopharmaceutical Co., Ltd. 24
Testing effectiveness (Phase 2)Ended earlyNCT03597022
What this trial is testing

Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors

Who this might be right for
Hemophilia A and B
Bayer 24
Post-approval studies (Phase 4)Study completedNCT01561391
What this trial is testing

Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 36
Post-approval studies (Phase 4)Study completedNCT01128881
What this trial is testing

IMMUNINE Pre-Treatment Study

Who this might be right for
Hemophilia B
Baxalta now part of Shire 57
Early research (Phase 1)Study completedNCT02571569
What this trial is testing

A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Bayer 32
Early research (Phase 1)Study completedNCT05651061
What this trial is testing

A Phase I of SS109 in Hemophilia A or and B With Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia B With InhibitorFactor VII Deficiency
Hangzhou Gensciences Biopharmaceutical Co., Ltd. 27
Large-scale testing (Phase 3)Looking for participantsNCT07545395
What this trial is testing

Safety of KN057 Prophylaxis in Patients With Haemophilia A or B

Who this might be right for
Hemophilia A or B
Suzhou Alphamab Co., Ltd. 70
Large-scale testing (Phase 3)Ended earlyNCT02484638
What this trial is testing

Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With Inhibitors

Who this might be right for
Hemophilia A With InhibitorsHemophilia B With Inhibitors
CSL Behring 25
Testing effectiveness (Phase 2)Study completedNCT00951405
What this trial is testing

Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 23
Early research (Phase 1)Study completedNCT02919800
What this trial is testing

A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male

Who this might be right for
Hemophilia A or B With Inhibitors
OPKO Health, Inc. 32
Testing effectiveness (Phase 2)Study completedNCT02541942
What this trial is testing

Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 19
Not applicableEnrolling By InvitationNCT06285071
What this trial is testing

Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors

Who this might be right for
Haemophilia AHaemophilia B
Novo Nordisk A/S 23
Load More Results